CLDN18 and familial pancreatic carcinoma: Among them, pancreatic cancer cells in the cluster 8 with TIMP1+/FN1+ showed the strongest resistance, while the cluster 1 with CLDN18-/CEACAM5- and the cluster 7 with HSPA6+/NEAT1+ showed milder resistance.